AGEN Price / FCF | AGENUS INC

AGENUS INC Price-FCF Ratio

The price-to-free-cash-flow (P/FCF) ratio tells you how many dollars investors pay for each dollar of cash a company generates after paying for its capital spending. It is market capitalization divided by free cash flow over the trailing four quarters, meaning the four most recent filed quarters added together, and the table shows both amounts. A higher ratio means investors are paying more for each dollar of free cash flow; a negative ratio means the company spent more cash than it generated over those quarters. Each point uses the filed share count and the last closing price on or before that quarter-end date, never today's price.

AGENUS INC price-fcf ratio for the quarter ending 2026-06-30 was -1.32, a change of -0.25 year-over-year.
AGENUS INC price-fcf ratio for the quarter ending 2026-03-31 was -1.47, a change of -1.19 year-over-year.
AGENUS INC price-fcf ratio for the quarter ending 2025-12-31 was -1.44, a change of -1.03 year-over-year.
AGENUS INC price-fcf ratio for the quarter ending 2025-09-30 was -1.42, a change of -0.73 year-over-year.
AGENUS INC price-fcf ratio for fiscal 2026 was -1.32.
AGENUS INC price-fcf ratio for fiscal 2025 was -1.44, a change of -1.03 from fiscal 2024.
AGENUS INC price-fcf ratio for fiscal 2024 was -0.41, a change of 0.99 from fiscal 2023.
AGENUS INC price-fcf ratio for fiscal 2023 was -1.4, a change of 61.46 from fiscal 2022.

Available history: 2011-09-30 to 2026-06-30
Data captured: 2026-06-30

Historical Price-FCF Ratio

Date	Price-FCF Ratio	Market capitalization	Free cash flow 12 month
2026-06-30	-1.32	$129.55M	-$98.5M
2026-03-31	-1.47	$128.28M	-$87.53M
2025-12-31	-1.44	$110.91M	-$77.2M
2025-09-30	-1.42	$126.99M	-$89.31M
2025-06-30	-1.07	$136.52M	-$127.87M
2025-03-31	-0.27	$40.11M	-$146.29M
2024-12-31	-0.41	$64.76M	-$158.89M
2024-09-30	-0.7	$118.83M	-$170.79M
2024-06-30	-1.9	$353.86M	-$186.18M
2024-03-31	-1.15	$243.53M	-$212.01M
2023-12-31	-1.4	$327.33M	-$234.16M
2023-09-30	-33.61	$8.58B	-$255.22M
2023-06-30	-47.62	$11.16B	-$234.44M
2023-03-31	-42.78	$9.92B	-$231.87M
2022-12-31	-62.85	$14.36B	-$228.44M
2022-09-30	-57.36	$11.39B	-$198.64M
2022-06-30	-247.19	$10.32B	-$41.74M
2022-03-31	-329.65	$12.42B	-$37.66M
2021-12-31	-685.77	$16.23B	-$23.67M
2021-09-30	-851.68	$24.02B	-$28.2M
2021-06-30	-141.25	$23.97B	-$169.69M
2021-03-31	-72.68	$10.93B	-$150.35M
2020-12-31	-83.25	$11.87B	-$142.56M
2020-09-30	-103.63	$14.4B	-$138.97M
2020-06-30	-96.93	$13.1B	-$135.1M
2020-03-31	-136.39	$7.77B	-$56.97M
2019-12-31	206	$10.97B	$53.27M
2019-09-30	139.94	$6.95B	$49.69M
2019-06-30	149.46	$7.91B	$52.89M
2019-03-31	-436.37	$7.82B	-$17.93M
2018-12-31	-41.59	$5.6B	-$134.76M
2018-09-30	-38.07	$4.76B	-$124.97M
2018-06-30	-36.57	$4.63B	-$126.71M
2018-03-31	-76.51	$9.48B	-$123.92M
2017-12-31	-65.8	$6.41B	-$97.42M
2017-09-30	-94.59	$8.63B	-$91.24M
2017-06-30	-167.88	$7.61B	-$45.31M
2017-03-31	-154,671.22	$7.28B	-$47,040.00
2016-12-31	-895.33	$7.05B	-$7.87M
2016-09-30	-1,574.14	$12.26B	-$7.79M
2016-06-30	-150.57	$6.91B	-$45.87M
2016-03-31	-91.97	$7.06B	-$76.81M
2015-12-31	-148.57	$7.54B	-$50.77M
2015-09-30	-178.57	$7.61B	-$42.63M
2015-06-30	-381.24	$12.11B	-$31.76M
2015-03-31	-256.41	$7.12B	-$27.79M
2014-12-31	-118.97	$4.88B	-$41.05M
2014-09-30	-111.08	$3.83B	-$34.44M
2014-06-30	-128.59	$3.93B	-$30.59M
2014-03-31	-146.69	$3.87B	-$26.37M
2013-12-31	-90.34	$1.84B	-$20.35M
2013-09-30	-88.76	$1.62B	-$18.22M
2013-06-30	-122.19	$2.11B	-$17.23M
2013-03-31	-131.99	$1.93B	-$14.64M
2012-12-31	2,176.86	$1.98B	$909,160.00
2012-09-30	10,507.29	$2.21B	$210,680.00
2012-06-30	5,751.12	$2.34B	$407,460.00
2012-03-31	-8,478.48	$2.91B	-$343,655.00
2011-12-31	-51.66	$842.21M	-$16.3M
2011-09-30	-465.32	$6.32B	-$13.58M

Annual Price-FCF Ratio

Date	Price-FCF Ratio	Market capitalization	Free cash flow 12 month
2026-06-30	-1.32	$129.55M	-$98.5M
2025-12-31	-1.44	$110.91M	-$77.2M
2024-12-31	-0.41	$64.76M	-$158.89M
2023-12-31	-1.4	$327.33M	-$234.16M
2022-12-31	-62.85	$14.36B	-$228.44M
2021-12-31	-685.77	$16.23B	-$23.67M
2020-12-31	-83.25	$11.87B	-$142.56M
2019-12-31	206	$10.97B	$53.27M
2018-12-31	-41.59	$5.6B	-$134.76M
2017-12-31	-65.8	$6.41B	-$97.42M
2016-12-31	-895.33	$7.05B	-$7.87M
2015-12-31	-148.57	$7.54B	-$50.77M
2014-12-31	-118.97	$4.88B	-$41.05M
2013-12-31	-90.34	$1.84B	-$20.35M
2012-12-31	2,176.86	$1.98B	$909,160.00
2011-12-31	-51.66	$842.21M	-$16.3M

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
C4 Therapeutics, Inc. (CCCC)	United States	$0.373B	-5.65
FENNEC PHARMACEUTICALS INC. (FENC)	United States	$0.371B	-115.85
Surrozen, Inc./DE (SRZN)	United States	$0.395B
Zura Bio Ltd (ZURA)		$0.398B	-6.56
Artiva Biotherapeutics, Inc. (ARTV)	United States	$0.367B
Cabaletta Bio, Inc. (CABA)	United States	$0.365B	-2.81
Scribe Therapeutics, Inc. (SCTX)	United States	$0.410B
Ocugen, Inc. (OCGN)	United States	$0.343B	-6.34
Editas Medicine, Inc. (EDIT)	United States	$0.424B	-4.29
Kyverna Therapeutics, Inc. (KYTX)	United States	$0.434B	-3.60